Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

22nd Century Group, Inc. is a leading plant biotechnology company. Cannin’s Analysts recently performed a fundamental analysis of this hemp stock – buy why is 22nd Century stock a strong buy?

Well, 22nd Century remains focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing and modern plant breeding. Seems interesting enough but is 22nd Century stock a strong buy?

Follow along as we guide you through Cannin’s deep-dive fundamental analysis of 22nd Century Group.

Related: Four Cannabis Stocks for Summer 2021

Best Cannabis Stocks 2021

22nd Century’s primary mission in tobacco is to reduce the harm caused by smoking by bringing our proprietary reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes – to adult smokers in the U.S. and international markets.

Meanwhile, the company’s primary mission in the hemp/cannabis space is to develop proprietary hemp/cannabis plants with valuable cannabinoid profiles and agronomic traits and to commercialize those plants through a synergistic portfolio of strategic partnerships in the hemp/cannabis industry.

Download 22nd Century Group’s Investor Presentation Now

22nd Century Company Profile

HQ: Williamsville, NY, USA
Founded: 1998
Symbol: XXII (NYSE)

Company Focus: Strong

22nd Century is a plant biotech company focused on developing technology to control the amount of nicotine in tobacco (primarily lower it to reduce harm)—and the level of cannabinoids in cannabis, through plant breeding and genetics. They have a worldwide license agreement with Anandia Labs in Canada for IP in hemp and cannabis plant genetics.

22nd Century Size: Strong

Market Cap: US $723
Enterprise Value: $692
# of employees: 79

Related: 22nd Century Group Provides Business Update

Best Hemp Stocks 2021 - Cannin Report

22nd Century Operations: Strong

Cultivation: None large scale. They are in the genetics stage though.

Distribution: None yet. They plan on profiling, breeding, cultivating and extracting plants in the future through their strategic partnerships.

Vertically integrated: Yes
Horizontally diversified: Yes

Related: CV Sciences Patent for CBD Nicotine Chewing Gum

22nd Century Management: Neutral

CEO: James Mish
COO: Michael Zercher
CRO: John Franzino

22nd Century Branding: Neutral

Their SPECTRUM line features 24 styles, in regular and menthol versions, with a fixed level of tar but 8 different levels of nicotine. These vary from Very Low Nicotine (VLN) cigarettes (95% less than normal) to relatively high nicotine yields. Finalizing FDA authorizations this year.

Related: 4 Hot Hemp Stocks to Buy Now

Hemp, Inc. Part of Select Group of Competitors in New Global Report

22nd Century Valuation: Neutral

Current share price: US $4.47
52 week high/low: $0.55-6.07
Price to Sales: 22.40
EV/Revenue: 24.87
Price/book: 13.78

22nd Century Financing: Strong

They recently sold 10 million shares at $4 per share for $40 million in proceeds. This should finance them for the next few years. Prior to this, operating cash flow was around negative $15 million!

Related: AXIM Biotech’s Patent for Cannabinoid Chewing Gum

Risks: High

The risks of investing in any cannabis or hemp company are very high given the immaturity of the market and all the aggressive competitors. The risk of investing in 22nd Century are somewhat higher given lack of revenue in their cannabis and hemp business arm, presence in the cigarette industry which is always seen as negative, and overall poor cash flow. But is this hemp stock still a strong buy?

Related: cbdMD – Should You Remain Bullish on this Hemp Stock?

CanninPlus Best Cannabis Stocks 2021

Bottom Line: Why is 22nd Century Stock a Strong Buy?

Cannin’s Recommendation for 22nd Century Stock: Strong

22nd Century Group is a biotechnology company trying to lower nicotine levels in tobacco plants and cannabinoids in hemp and cannabis plants through genetic engineering, gene-editing, and plant breeding.

They have nicotine products with 95% less nicotine than conventional cigarettes as one of their products. Yes, this may seem risky given the regulatory environment around smoking but they are working with the FDA to decrease the addictive nature of these products and may secure FDA authorization for VLN (their low nicotine products).

Mainly though, they try to increase their value using IP (patents etc) with over 200 issued and pending patents in plant-based applications.

Related: AFC Gamma Announces Launch of Common Stock Offering

In fact, they just raised $40 million through sales of common stocks and this should keep them well financed for the next 2-3 years. They have partnerships with Anandia Labs, Aurora Cannabis, CannaMetrix, KeyGene, Needle Rock Farms, and Panacea all to improve value along the plant cultivation process. Admittedly, the Aurora partnership is especially attractive given the distribution of any successful patents.

Download 22nd Century Group’s Investor Presentation Now

Their P/S, EV/Revenue, and P/B are all a bit too high now but if they continue to drop, this stock could be quite a deal. Q1 2021 they had almost $7 million in sales (but $5 million in losses). Total assets are almost $60 million with total liabilities at $7 million. They are also being added to the Russell 2000 index!

For all these reasons, we give them a Strong rating for 2021. If they can continue to release promising IP and press releases, we think the stock price should increase for the rest of 2021.

Why is 22nd Century Stock a Strong Buy?

Cannin Investment Group: Your Hemp Stocks Experts

Cannin Report Q1 is your trusted resource for top hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2021. 

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now. 

Are you interested in the best hemp stocks for 2021 like HempFusion, Inc., Charlotte’s Web, Canopy Growth, or Hemp Inc.?

If so, are you looking to buy stock in hemp companies or stock in cannabis companies in 2021? Interested in penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +30% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at